The need for and the challenges of measuring renal sympathetic nerve activity.

Renal denervation (RDN) was primarily developed to treat hypertension and is potentially a new method for treating arrhythmias. Because of the lack of a standardized protocol to measure renal sympathetic nerve activity, RDN is administered in a blind manner. This inability to assess efficacy at the time of treatment delivery may be a large contributor to the ambiguity of RDN outcomes reported in the hypertension literature.

Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.

The ability to generate human pluripotent stem cell-derived cell types at sufficiently high numbers and in a reproducible manner is fundamental for clinical and biopharmaceutical applications. Current experimental methods for the differentiation of pluripotent cells such as human embryonic stem cells (hESC) rely on the generation of heterogeneous aggregates of cells, also called "embryoid bodies" (EBs), in small scale static culture. These protocols are typically (1) not scalable, (2) result in a wide range of EB sizes and (3) expose cells to fluctuations in physicochemical parameters.

Magnetoelectroanatomic mapping of arrhythmias in structural heart disease using a novel multielectrode catheter:

Electroanatomic mapping with CARTO requires point-by-point acquisition using the mapping catheter's bipolar tip electrode. This study evaluates the utility of a novel 26-electrode catheter (Qwikstar) for electroanatomic mapping of arrhythmias in patients with structural heart disease. The multielectrode catheter acquires activation times and anatomic data simultaneously from its tip and shaft electrodes.